English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/173638
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Quantitative comparison of DNA methylation assays for biomarker development and clinical applications

AuthorsBock, Christoph; Halbritter, Florian; Carmona, Francsico J.; Tierling, Sascha; Datlinger, Paul; Assenov, Yassen; Berdasco, María; Bergmann, Anke K.; Booher, Keith; Busato, Florence; Campan, Mihaela; Dahl, Christina; Dahmcke, Christina M.; Diep, Dinh; Fernández, Agustín F.; Gerhauser, Clarissa; Haake, Andrea; Heilmann, Katharina; Holcomb, Thomas; Hussmann, Dianna; Ito; Mitsuteru; Kläver, Ruth; Kreutz, Martin; Kulis, Marta; López, Virginia; Nair, Shalima S.; Paul, Dirk S.; Plongthongkum, Nongluk; Qu, Wenjia; Queirós, Ana C.; Reinicke, Frank; Sauter, Guido; Schlomm, Thorsten; Statham, Aaron; Stirzaker, Clare; Strogantsev, Ruslan; Urdinguio, Rocío G.; Walter, Kimberly; Weichenhan, Dieter; Weisenberger, Daniel J.; Beck, Stephan; Clark, Susan J.; Esteller, Manel; Ferguson-Smith, Anne C.; Fraga, Mario F.; Guldberg, Per; Lotte Hansen, Lise; Laird, Peter W.; Martín, José Ignacio ; Nygren, Anders O. H.; Peist, Ralf; Plass, Christoph; Shames, David S.; Siebert, Reiner; Sun, Xueguang; Tost, Jörg; Walter, Jörn; Zhang, Kun
Issue Date2016
PublisherSpringer Nature
CitationNature Biotechnology 34(7): 726-737 (2016)
AbstractDNA methylation patterns are altered in numerous diseases and often correlate with clinically relevant information such as disease subtypes, prognosis and drug response. With suitable assays and after validation in large cohorts, such associations can be exploited for clinical diagnostics and personalized treatment decisions. Here we describe the results of a community-wide benchmarking study comparing the performance of all widely used methods for DNA methylation analysis that are compatible with routine clinical use. We shipped 32 reference samples to 18 laboratories in seven different countries. Researchers in those laboratories collectively contributed 21 locus-specific assays for an average of 27 predefined genomic regions, as well as six global assays. We evaluated assay sensitivity on low-input samples and assessed the assays' ability to discriminate between cell types. Good agreement was observed across all tested methods, with amplicon bisulfite sequencing and bisulfite pyrosequencing showing the best all-round performance. Our technology comparison can inform the selection, optimization and use of DNA methylation assays in large-scale validation studies, biomarker development and clinical diagnostics.
DescriptionThe BLUEPRINT consortium
Publisher version (URL)https://doi.org/10.1038/nbt.3605
Identifiersdoi: 10.1038/nbt.3605
e-issn: 1546-1696
issn: 1087-0156
Appears in Collections:(CINN) Artículos
(CNB) Artículos
Files in This Item:
File Description SizeFormat 
quantiappli.pdf4,13 MBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.